Ameritas Investment Partners, Inc. Magenta Therapeutics, Inc. Transaction History

Ameritas Investment Partners, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.97 - $3.08 $1,667 - $5,294	-1,719 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$6.03 - $15.24 $3,201 - $8,092	531 Added 44.7%	1,719 $11,000
Q1 2019 May 15, 2019	BUY	$5.7 - $19.7 $4,890 - $16,902	858 Added 260.0%	1,188 $20,000
Q3 2018 Nov 13, 2018	BUY	$11.32 - $15.7 $3,735 - $5,181	330 New	330 $4,000

442K

Ticker MGTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,890,500
Description
Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.